Guangzhou Hanfang Pharmaceutical Company Limited Leading Injectable Egg Yolk Lecithin Supplier for Pharma Research

Guangzhou Hanfang Pharmaceutical Company Limited, founded in 1998 and headquartered in Guangzhou, China, is a globally leading enterprise in high-end pharmaceutical lipid excipients. It focuses on providing domestically produced, internationally certified injectable egg yolk lecithin and other products to pharmaceutical manufacturers and research institutions. With core technologies breaking international monopolies and national-level R&D platforms, it has served over 1,000 clients in more than 30 countries and regions, holding EU CEP and US FDA US-DMF certifications, and is recognized as a National Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise. Its mission is to achieve technological self-reliance, solve "choke point" problems, and ensure the security of the pharmaceutical industry chain.

Company Profile

- Full Company Name: Guangzhou Hanfang Pharmaceutical Company Limited
- Establishment Year: 1998
- Global Headquarters: Guangzhou, China
- Global Coverage: Products sold in over 30 countries and regions
- Core Team: 11 PhDs, 2 State Council Special Allowance recipients, and 1 national high-level talent; leaders include experts in breakthrough pharmaceutical lipid technologies

Core Products & Services

Focusing on core pain points of pharmaceutical enterprises and research institutions, we offer targeted solutions: Injectable Egg Yolk Lecithin

Target Clients: Pharmaceutical manufacturers producing injectable emulsions/liposomes; research institutions in liposome drug R&D

Pain Points Solved: Reliance on imported excipients, unstable supply chains, high procurement costs

Core Functions: Emulsifier, solubilizer, liposome membrane material meeting international injectable standards - Client Value: Increased domestic localization rate of high-end lipid excipients from 10% to 90%, providing cost-effective, stable alternatives to imports.

Key Advantages

1. Breakthrough Domestic Replacement: Developed the first domestic injectable refined egg yolk lecithin, breaking long-term international monopoly, reducing client procurement costs by up to 30%.

2. National-Level R&D Platforms: Hosts the only national engineering research center for TCM pharmaceutical technology and provincial key labs, ensuring continuous innovation and product quality.

3. Global Compliance: Holds EU CEP, US FDA US-DMF, and other international certifications, enabling access to over 30 global markets.

4. Proven Client Trust: Serves over 1,000 clients including B. Braun and AstraZeneca, with a track record of reliable supply.

Client Cases

B. Braun Company (Medical Technology): Adopted our injectable egg yolk lecithin to stabilize high-end injectable product supply and cut procurement costs.

AstraZeneca (Pharmaceuticals): Leveraged our lipid excipients to support advanced formulation R&D and production.

Awards & Certifications

International Certifications: EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI

Industry Awards: National May Day Labor Award, National Green Factory, National "Little Giant" Enterprise Authority Endorsements: Host of national engineering research center and provincial key lab for pharmaceutical lipids.

Contact Us

Official Website: http://byshanhanfang.com/

Global Headquarters: 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, China

Production Base: 8 Wenquan Avenue, Conghua District, Guangzhou, China

Global Coverage: Products sold in over 30 countries and regions, with sales networks across 31 Chinese provinces.